Publications by authors named "Lijia Ou"

Article Synopsis
  • Fibrosis is a serious condition linked with many chronic inflammatory diseases, and pyroptosis, a new form of programmed cell death, is increasingly recognized for its role in these fibrotic diseases, prompting research into their connection.* -
  • The study analyzed 566 articles related to pyroptosis and fibrosis from 2010 to 2024 using various bibliometric methods, revealing trends in publication with a significant contribution from China and the USA.* -
  • Key findings showed continuous growth in publications, with Feldstein, A. E. being the most prolific author, and outlined that the top-cited articles focus on how specific proteins facilitate pyroptotic cell death, highlighting major research keywords like pyroptosis and fibrosis.*
View Article and Find Full Text PDF
Article Synopsis
  • Proliferative verrucous leucoplakia (PVL) is a rare but aggressive oral lesion with a significant risk of malignant transformation, prompting the need for thorough bibliometric analysis of global research on the topic.
  • This study aimed to evaluate the academic output, impact, and collaboration patterns related to PVL by analyzing publication data over the last 20 years.
  • Findings revealed a slow but steady increase in publications, with significant contributions from the USA, Spain, and UK, and highlighted key authors and prominent keywords in the field.
View Article and Find Full Text PDF

This paper introduces two cases of multiple myeloma, COVID-19 infection during autologous stem cell transplantation, the treatment process, and different results of the two patients, which provides a reference for how to carry out ASCT safely during the COVID-19 normalization stage.

View Article and Find Full Text PDF

Purpose: This study aims to elucidate the biological functions of ferroptosis-related genes in periodontitis, along with their correlation to tumor microenvironment (TME) features such as immune infiltration. It aims to provide potential diagnostic markers of ferroptosis for clinical management of periodontitis.

Methods: Utilizing the periodontitis-related microarray dataset GSE16134 from the Gene Expression Omnibus (GEO) and a set of 528 ferroptosis-related genes identified in prior studies, this research unveils differentially expressed ferroptosis-related genes in periodontitis.

View Article and Find Full Text PDF

Fibrosis is one of the most worrisome complications of chronic inflammatory diseases, leading to tissue damage, organ failure, and ultimately, death. The most notable pathological characteristic of fibrosis is the excessive accumulation of extracellular matrix (ECM) components such as collagen and fibronectin adjacent to foci of inflammation or damage. The human microfibrillar-associated protein 4 (MFAP4), an important member of the superfamily of fibrinogen-related proteins, is considered to have an extremely important role in ECM transformation of fibrogenesis.

View Article and Find Full Text PDF

Central nervous system lymphoma (CNSL) is an aggressive non-Hodgkin's lymphoma (NHL) confined to the central nervous system (CNS). Orelabrutinib is an oral second-generation Bruton tyrosine kinase (BTK) inhibitor and a novel therapeutic strategy for CNSL. The purpose of this study was to evaluate the effectiveness and safety of high-dose methotrexate (HD-MTX), thiotepa, and orelabrutinib combined with or without rituximab (MTO±R)regimen in the treatment of patients with CNSL.

View Article and Find Full Text PDF

CAR-T cell therapy, a novel therapeutic approach that has attracted much attention in the field of cancer treatment at present, has become the subject of many studies and has shown great potential in the treatment of hematological malignancies, such as leukemia and lymphoma. This study aims to analyze the characteristics of articles published on CAR-T cell therapy in the lymphoma field and explore the existing hotspots and frontiers. The relevant articles published from 2013 to 2022 were retrieved from the Web of Science Core Collection.

View Article and Find Full Text PDF

Diffuse large B-cell lymphoma (DLBCL) is the most common lymphoma subtype. Treatment of DLBCL has improved greatly in recent decades, with thousands of papers published. We conducted a bibliometric analysis of the literature on DLBCL treatment, and discussed cooperation among authors, countries, and institutions, and identified research hotspots for DLBCL treatment.

View Article and Find Full Text PDF